Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,033 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

for
Autosomal Dominant Polycystic Kidney Disease
Location: Orlando FL, Jacksonville FL, Baltimore MD, Lenexa KS,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT07228364

Phase 1, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Orlando FL, Ocala FL, St. Petersburg FL,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease

for
Hepatic Impairment, Healthy, Hepatic Insufficiency,
Location: Orlando FL, Tampa FL, Miami Lakes FL
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07677358

Phase 1, Recruiting

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for
Prostate Cancer
Location: Orlando FL, Tampa FL, Commack NY, Grand Rapids MI,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07192614

Phase 1, Phase 2, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Orlando FL, Jacksonville FL, Miami FL, Charleston SC,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Location: Orlando FL, Maitland FL, Orange City FL, Tampa FL,
Sponsor: Tonix Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07621237

Phase 2, Recruiting

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for
Endometrial Cancer, Malignant Solid Tumour
Location: Orlando FL, New Port Richey FL, Jupiter FL,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07044336

Phase 3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Orlando FL, Maitland FL, Longwood FL, DeLand FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib

for
Healthy, Hepatic Impairment
Location: Orlando FL, Miami FL, San Antonio TX
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18 - 70+

Code: NCT06997276

Phase 1, Recruiting

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced / Metastatic Solid Tumors
Location: Orlando FL, Sarasota FL, Birmingham AL, Nashville TN,
Sponsor: Crescent Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07335497

Phase 1, Phase 2, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Orlando FL, DeBary FL, Tampa FL, Clearwater FL,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06883305

Phase 3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Orlando FL, Clermont FL, Orange City FL, Gainesville FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

for
Binge-Eating Disorder
Location: Orlando FL, Jacksonville FL, Fort Myers FL,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT06413433

Phase 3, Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

for
Polymyositis, Dermatomyositis
Location: Orlando FL, Plant City FL, Palm Beach Gardens FL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06455449

Phase 3, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Orlando FL, Lakeland FL, Crystal River FL,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase 3, Recruiting

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

for
COPD (Chronic Obstructive Pulmonary Disease)
Location: Orlando FL, Kissimmee FL, Edgewater FL, Lakeland FL,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06283966

Phase 3, Recruiting

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

for
Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension,
Location: Altamonte Springs FL, Maitland FL, Orlando FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07783802

Phase 2, Recruiting

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

for
SLE, SLE (Systemic Lupus)
Location: Orlando FL, Memphis TN, Webster TX, New York NY,
Sponsor: Cullinan Therapeutics Inc.

Sex: All

Age: 18 - 70

Code: NCT06613360

Phase 1, Recruiting
New

Flutemetamol F 18 Injection Formulation Comparison

for
Cognitive Dysfunction
Location: Winter Park FL, Aventura FL, Miami FL, Gainesville GA
Sponsor: GE Healthcare

Sex: All

Age: 50 - 70+

Code: NCT07873463

Phase 2, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for
Atrial Fibrillation (AF)
Location: Winter Park FL, New Smyrna Beach FL, Inverness FL,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase 3, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando